HomeSonavex, Inc.

Sonavex, Inc.

Sonavex Receives FDA 510(k) Clearance for EchoMark & EchoMark LP Tissue Markers

6/8/18: “After four years of development and testing, we are excited to start using EchoMark at the bedside,” said Devin O’Brien Coon, MD, Sonavex President and Study Director for the pivotal 510(k) study. "We believe that surgical ultrasound is an underutilized tool with the potential to dramatically change patient management – for the better."